Nubequo Tablets 300mg, with the ingredient Darolutamide, are produced by Bayer Pharmaceutical. This medication (YJ code: 4291063F1025, 300mg x 1 tablet) is an androgen receptor inhibitor indicated for the treatment of adults with non-metastatic castration-resistant prostate cancer (nmCRPC), metastatic castration-sensitive prostate cancer (mCSPC), and mCSPC in combination with docetaxel.
Nubequo Tablets 300mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →